US-based Wasatch Advisors buys stakes in Dr Lal PathLabs taking total to 7.04%
US-based Wasatch Advisors Inc on Monday bought 2 per cent stakes in Dr. Lal PatLabs Limited.
Source: freepressjournal.in
📰 Lal Pathlab News
Page 2 - Lal Pathlab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lal Pathlab. Real-time updates on events, politics, business and more.
Dr Lal Pathlabs Ltd (DLPL): March '22 Results Update
Dr Lal Pathlab (DLPL) came out with its quarterly earnings recently; the results were lacklustre.
Source: moneylife.in
Stock Market LIVE: Sensex, Nifty likely to open lower today
Indian market surged for the third straight session on Thursday amid positive global cues. Sensex closed 460 points higher at 58,926 and Nifty rose 142 points to end at 17,605.
Source: businesstoday.in
Dr Lal Pathlabs' stock slips ~4% owing to frail Q3FY22 numbers
Its EBITDA witnessed a decline of 21.3% yoy at Rs109 crore in Q3FY22 against Rs139 crore in Q3FY21.
Source: indiainfoline.com
Dr Lal's Pathlabs Ltd: September '21 Results & Acquisition Update
We had covered Dr Lal’s Pathlab in detail a month ago here. Its quarterly earnings report is out and it has also announced acquisition of Suburban Diagnostics.
Source: moneylife.in
Sensex makes a strong start led by financial stocks; HPCL, India Cements surge 5%
Sensex rebounds on positive global cues: What else is driving Dalal Street today SECTIONS Last Updated: May 21, 2021, 09:48 AM IST Share Synopsis SBI, Concor, Crompton, Godrej Industries, Hindalco and JSW Steel are some of the companies due to post their Q4 results on Wednesday. Analysts awaited more quarterly earnings announcements from India Inc for cues. INSIGHTS NSE Explore Now NEW DELHI: Benchmark indices were off to a positive start on Friday led by across-the-board buying. Domestic s...
Source: indiatimes.com
Corona resurgence: Labs testing Covid-19 samples in Delhi overburdened
Corona resurgence: Labs testing Covid-19 samples in Delhi overburdened By IANS | 1 Views Preparations in full swing to vaccinate all against corona: PM Image Source: IANS News New Delhi, April 13 : With an exponential resurgence in Coronavirus cases over the last few weeks, many private laboratories taking Covid-19 samples are overburdened and have stopped collecting new samples. Many private labs IANS spoke to said they have stopped receiving Covid-19 samples until the existing sampl...
Source: prokerala.com
Dr Lal PathLabs hits record high in a weak market; surges 19% in 5 days
Shares of Dr Lal PathLabs hit a record high of Rs 2,924.85, ralling 7 per cent on the BSE in the intra-day trade on Monday, on expectation of healthy earning growth in the near-term, as the company would continue to reap benefits from increased Covid-related and allied testing in its widespread network of diagnostic centers and labs. At 11:03 am, the S&P BSE Sensex was down 2.6 per cent at 48,744 points while the stock was quoting higher for the fifth straight trading day. The stock has rallied...
Source: business-standard.com
Dr Lal Pathlabs - Maintains superior execution - ICICI Securities
Dr Lal Pathlabs - Maintains superior execution - ICICI Securities
Source: equitybulls.com